logo

Bellerophon Therapeutics Llc (BLPH)



Trade BLPH now with
  Date
  Headline
1/25/2019 4:11:08 PM Bellerophon Announces Closing Of $7 Mln Public Offering Of Common Stock
1/23/2019 6:01:35 AM Bellerophon Therapeutics Prices Public Offering Of 10 Mln Shares At $0.70 Per Share
1/22/2019 4:48:58 PM Bellerophon Therapeutics Announces Proposed Public Offering Of Common Stock
1/7/2019 8:36:14 AM Bellerophon Therapeutics Reports Top-line Results From Cohort 1 Of INOpulse Phase 2b Clinical Trial
11/7/2018 8:36:43 AM Bellerophon Therapeutics Q3 Net Income $11.1 Mln Or $0.19/shr Vs. Net Loss Of $7.6 Mln Or $0.22/shr Prior Year
5/10/2018 8:47:57 AM Bellerophon Therapeutics Q1 Net Income $4.1 Mln Or $0.07/shr Vs Net Loss Of $19.1 Mln Or $0.60/shr Prior Year
5/8/2018 8:36:11 AM Bellerophon Reaches Agreement With FDA On Study Design Of Phase 2b Trial Of INOpulse
1/3/2018 8:35:48 AM Bellerophon Announces First Patient Enrolled In Phase 2b Study Evaluating INOpulse